Project Grant HT94252510390
Award Date
8/15/25
Completion Date
8/14/27
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New Orleans, LA 70118, USA
Similar Awards
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $999,465.00 to the University of Houston System to conduct research on selective spleen-targeted nanoparticles as drug delivery vehicles for the treatment of lupus. The research aims to advance disease prevention, diagnosis, treatment, and management of this condition through basic, applied, and translational research initiatives. The award...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
This $779,401 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support lung cancer research led by Tulane University. The 3-year grant, effective July 1, 2024, will fund the Lung Cancer Research Program Idea Development Award, which aims to advance innovative scientific studies around lung cancer prevention, diagnosis, and treatment. As a prime grantee, Tulane University will conduct research and...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $872,914 to Tulane University to conduct research on "Mast Cell Activation as a Mediator of Persistent Neurological Symptoms Partly Mediated Through a Novel Matrix Metalloproteinase." The award period runs from September 1, 2024 to August 31, 2027. The Military Medical Research and Development program supports a broad range of biomedical research...
This Project Grant award of $997,821.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee is Trustees of Dartmouth College, who will conduct this research over a three-year period from November 1, 2024 to October 31, 2027. The project involves two sub-awards: one to The Johns Hopkins University to contribute expertise, and...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
The Medical University of South Carolina will research N-glycans and glycosphingolipids as biomarkers and modulators of lupus nephritis under a $750,000 Project Grant from the Department of the Army Medical Command. The funding supports the Military Medical Research and Development program's goal of transforming health care for service members and the public through innovative biomedical research solutions for the battlefield. Through this three-year award beginning September 30, 2022, the...